Ask the GAO Cyber Expert
Client Alert | 1 min read | 01.30.13
On February 20 at noon at Crowell & Moring, the ABA's Public Contract Law (PCL) and Science and Technology (SciTech) Sections will co-sponsor "Information Security, Privacy and the Government Accountability Office," featuring Greg Wilshusen, GAO's top cybersecurity and privacy expert, addressing his testimony and reports to Congress on topics such as cyber threats, mobile device security, IT supply chain challenges, and critical infrastructure risks for federal agencies and government contractors. With Sharon Larkin (Chair-Elect, ABA PCL Section; GAO Contract Appeals Judge & Assistant General Counsel, Procurement Law) providing opening remarks and David Bodenheimer (C&M Partner; ABA SciTech Chair, Security, Privacy & Information Law Division) moderating, you should register here, for the opportunity to bring your best questions for Mr. Wilshusen, who has been one of the foremost thought leaders reporting and testifying on cybersecurity and privacy challenges in the public sector arena.
Contacts
Insights
Client Alert | 4 min read | 12.04.25
District Court Grants Preliminary Injunction Against Seller of Gray Market Snack Food Products
On November 12, 2025, Judge King in the U.S. District Court for the Western District of Washington granted in part Haldiram India Ltd.’s (“Plaintiff” or “Haldiram”) motion for a preliminary injunction against Punjab Trading, Inc. (“Defendant” or “Punjab Trading”), a seller alleged to be importing and distributing gray market snack food products not authorized for sale in the United States. The court found that Haldiram was likely to succeed on the merits of its trademark infringement claim because the products at issue, which were intended for sale in India, were materially different from the versions intended for sale in the U.S., and for this reason were not genuine products when sold in the U.S. Although the court narrowed certain overbroad provisions in the requested order, it ultimately enjoined Punjab Trading from importing, selling, or assisting others in selling the non-genuine Haldiram products in the U.S. market.
Client Alert | 21 min read | 12.04.25
Highlights: CMS’s Proposed Rule for Medicare Part C & D (CY 2027 NPRM)
Client Alert | 11 min read | 12.01.25
